Theme: “Explore the Possibilities in the Field of Cancer and Tumorâ€
Cancer Immunology 2017
Conference Series invites all the participants across the globe to 10th International Conference on Cancer & Tumor Immunology October 26-27, 2017 Which deals with the advanced topics related to Cancer Immunology, Tumor Immunology Cancer and Tumor Research and therapy, Novel approaches in Cancer and Tumor , Infectious Diseases, Epidemiology and prevention, Healthcare delivery, Information, patients and the public which will cover the topics like Research Education and communication about cancer, Public policy issues, ethics and confidentiality Cancer Biology and model systems, the tumor microenvironment etc.
The Main theme of the conference is “Explore the Possibilities in the Field of Cancer and Tumor”.
Cancer Immunology 2017 will mainly target Fellows, Immunologists, oncologist’s nurse practitioners, nurses, pharmacist, physician assistants, researchers, and other health care professionals interested in the treatment of cancer and Tumor. Cancer Immunology 2017 conference acts as a bridge between academics and business to offer them a common platform to interact and share ideas.
Why to attend??
Cancer immunology offers the best and advanced technologies around the world focused on learning about Cancer and Immunology and its advances: this is your best opportunity to reach the largest assemblage of participants from Cancer Immunology community. conduct presentations, distribute information’s, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event, world renowned speakers, the most recent techniques, developments, and the newest updates in Cancer immunology are hallmarks of this conference.
Target Audience:
Track 1: Cancer Immunology:
Cancer immunology will outline the basic biology of immune responses with the goal of developing new immune therapy approaches and improving existing ones. Basic research to investigate, at the cellular and molecular levels, the mechanisms that regulate the immune system, yielding knowledge that will further our efforts to harness the power of the immune system to treat cancer.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan; International Conference on Cancer Biology R&D and Market June 21 - 22, 2017 Philadelphia, USA; USA 8th Molecular Immunology & Immunogenetics Congress March 20-21, 2017 Rome, Italy; 2nd International Congress on Contemporary Issues in Women Cancers and Gynaecologic Oncology Aug 28-29, 2017 London, UK; 9th International Conference on Haematology November 02-03, 2017 Las Vegas, USA; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology meetings March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference 27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Haematopoiesis January 31—February 4, 2017 Fairmont Banff Springs, Banff, Alberta, Canada; Cancer Immunotherapy conference EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference; 3rd EACR Conference on Cancer Genomics Cambridge, UK: 25 - 28 June 2017
Track 2: Tumor Immunology:
Tumor Immunology is determining the function and behaviour of innate and adaptive immune cells in health and disease, including the interactions with their microenvironment. Understanding the basic principles underlying immune cell development, activation, regulation, differentiation and death as well as the molecular mechanisms underlying diversity and plasticity of the immune system is a prerequisite for the design of targeted manipulation strategies to protect from cancer, autoimmunity and infection and to foster and devise the development of novel therapeutic approaches. To address their research questions the individual groups develop and use sophisticated experimental model systems and technologies such as structural biology, genetic barcoding and high-throughput single cell analysis platforms.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences:4th Asia Pacific Gastroenterology Cancer Summit, April 28-30, 2017 Singapore;9th International Conference on Clinical Haematology and Experimental Haematology OCTOBER 16-17, 2017 Rome, Italy; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 9th world congress & expo on Immunology conference, Oct 02-04, 2017, Toronto, Canada;25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; European Lung Cancer Conference, May 5-8, 2017, Switzerland; 2nd Paediatric Oncology Conference, June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology Meeting, Feb 13 2017 London, United Kingdom;
Track 3: Immunology & Immunotherapy:
Covers all areas of immunology including cellular and molecular immunology, immunochemistry, immunogenetics, imaging, mathematical modelling, allergy, transplantation immunology, cancer immunology, clinical immunology and immunological therapies, physiological functioning of the immune system in states of both health and disease, malfunctions of the immune system in immunological disorders and therapies (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection), the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo are of prime interest.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: Global Experts meeting on Oncology Conference Case Reports Aug 29-31, 2017 London, UK: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology Meeting May 17 to 20, 2017, Bangalore, India: ; 24th Asia Pacific Cancer meeting , June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.
Track 4: Inflammation and Cancer:
Prolonged inflammation can damage your body’s healthy cells and tissue, and weaken your immune system, the link between inflammation and cancers, cancers tended to occur at sites of chronic inflammation. Lately, it turned out that acute inflammation contributed to the regression of cancer. Inflammation and innate immunity are important targets in patients with cancer
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan; International Conference on Cancer Biology R&D and Market June 21 - 22, 2017 Philadelphia, USA; USA 8th Molecular Immunology & Immunogenetics Congress March 20-21, 2017 Rome, Italy; 2nd International Congress on Contemporary Issues in Women Cancers and Gynaecologic Oncology conference Aug 28-29, 2017 London, UK; 9th International Conference on Haematology November 02-03, 2017 Las Vegas, USA; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology Conference March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference 27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Haematopoiesis January 31—February 4, 2017 Fairmont Banff Springs, Banff, Alberta, Canada; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference; 3rd EACR Conference on Cancer Genomics Cambridge, UK: 25 - 28 June 2017.
Track 5: Cancer & HIV:
People with HIV/AIDS are at high risk for developing certain cancers, such as Kaposi's sarcoma, non-Hodgkin lymphoma, and cervical cancer. For people with HIV, these three cancers are often called "AIDS-defining conditions. Most types of cancer begin when normal cells begin to change and grow uncontrollably, forming a mass called a tumor. A tumor can be benign (noncancerous) or malignant (cancerous, meaning it can spread to other parts of the body).
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago; International Conference on Cancer & Tumor Immunology October 26-27, 2017Osaka, Japan; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; Paediatric Neuro-Oncology meeting, Feb 13 2017 London, United Kingdom; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference 27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; . Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; ; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference.
Track 6: Tumor Microenvironment:
Cancers are not just masses of malignant cells but complex ‘rogue’ organs, to which many other cells are recruited and can be corrupted by the transformed cells. Interactions between malignant and non-transformed cells create the tumor microenvironment. Changes of the tumor microenvironment have been closely correlated to cancer-mediated inflammation.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conference:2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA; 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA;3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore; Stem Cells and Cancer meeting Gordon Research Conference, February 12-17, 2017, Lucca (Barga), 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy ; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy; EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany;24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Italy; Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne.
Track 7: Cancer vaccines:
A cancer vaccine is a vaccine that treats with existing cancer or prevents development of a cancer. Cancer vaccines are also known as biological response modifiers. A biological response modifier helps by stimulating or restoring the immune system’s ability to fight infections and disease. The most commonly used side effect of cancer vaccines is inflammation at the site of injection, including redness, pain, swelling, warming of the skin, itchiness, and occasionally a rash. Mainly these vaccines include cell therapy and gene therapy.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: 9th world congress & expo on Immunology Conference, Oct 02-04, 2017, Toronto, Canada: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt.: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: ; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy: Stem Cells and Cancer meeting Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.
Track 8: Cancer prognosis:
Cancer prognosis gives us information about the percentage of people who survive a certain type of cancer for specific amount of time. Some of the factors that affect prognosis like type of cancer, its location in the body, stage, size of the cancer, cancer’s grade and age of the patients etc… The time of period varies; it may be 1 year, 2 years, 5 years, and etc... Cancer-specific survival is also called as Disease-specific survival. There are different ways to measure and report survival and statistics of cancer. This cancer prognosis that mainly include liver cancer prognosis, metastatic prognosis and brain cancer prognosis.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: 9th International Conference on Clinical Haematology and Experimental Haematology October 16-17, 2017 Rome, Italy; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka,Japan; International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference 27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; 6th World Oral Cancer Congress of the International Academy of Oral Oncology meeting May 17 to 20, 2017, Bangalore, India; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; ; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; 2nd International Conference on Pancreatic & Colorectal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA. European Lung Cancer Conference, May 05- 08 2017, Switzerland.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Track 9: Cancer Cell Biology:
Cancer cell biology can be defined as a disease of the genes. This is the small part of DNA and master molecule of the cell. The main two characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate and spread to distant sites. If the spread is not controlled, cancer can result in death. Bone marrow stromal stem cells also called mesenchyme stem cells or skeletal stem cells and these can generate bone, cartilage, and fat cells. The cancer pathology is a medical document that written by a pathologist. A pathologist is a doctor who specializes in interpreting laboratory tests and evaluating cells, tissues, and organs to diagnose disease.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India ; World Congress on Oncology and Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Integrating Metabolism and Immunity, May 29 - June 2, 2017 | Dublin, Ireland.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Track 10: Tumor biology:
Cells may acquire mutations in genes that control proliferation, such as tumor suppressor genes. Tumors grow in a series of steps. The first step is hyperplasia, resulting from uncontrolled cell division. These cells appear normal, but some changes occurred that results in loss of control of growth. The second step is dysplasia, resulting from further growth, accompanied by abnormal changes to the cells. The third step requires additional changes, which result in cells that are even more abnormal and can now spread over a wider area of tissue. These cells begin to lose their original function; such cells are called anaplastic. At this stage, the tumor is still contained within its original location (called in situ) and is not invasive, it is not considered malignant - it is potentially malignant. The last step occurs when the cells in the tumor metastasize, which means that they can invade surrounding tissue, including the bloodstream, and spread to other locations. This is the most serious type of tumor, but not all tumors progress to this point. These Tumor Biology that mainly Include Molecular and Cellular oncology and Immuno oncology.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore;24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India; February 9-11th 2017 - Mantra Lorne: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy. World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy;
Track 11: Economic Impact on Cancer:
Cancer care costs are a financial burden to patients, their families, and society as a whole. In 2006 medical expenses from cancer care in the United States were an estimated $104.1 billion. Cancer can be a major cause of lack of money. This may be due either to the costs of treating and managing the illness as well as its impact upon people's ability to work. This particularly affects countries that lack comprehensive social health insurance systems and other types of social safety nets. The study is a longitudinal short study of 10,000 hospital patients with a first time diagnosis of cancer. Patients were assigned a socioeconomic status according to the district of residence at diagnosis. Continuity of patients due to cancer living in the most deprived district was compared to survival of patients living in all other districts by model-based period analysis. These major regional socioeconomic inequalities indicate a potential for improving cancer care and survival in Germany. Studies on individual patient data with access to treatment information should be conducted to examine the reasons for these socioeconomic inequalities in cancer survival in more detail.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago; International Conference on Cancer & Tumor Immunology October 26-27,2017Osaka, Japan; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; Paediatric Neuro-Oncology meeting, Feb 13 2017 London, United Kingdom; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference 27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; ; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Track 12:Cancer Research:
The goal of the Cancer Research Program is to make significant improvements in the prevention, early detection, diagnosis and treatment of cancer. Research into the cause of cancer involves many different disciplines including genetics, diet, environmental factors (i.e. chemical carcinogens). And it will continue to translate basic research findings into clinical applications together with strategic partners, with the National Centre for Tumor Diseases (NCT) and the nationally active German Consortium for Translational Cancer Research (DKTK) playing key roles. The program is also developing new approaches in the fields of cancer genome and epigenome research, metabolic dysfunction, personalized radiation oncology and ion therapy, molecular imaging, neuro-oncology, individualized cancer medicine and health economics.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan; International Conference on Cancer Biology R&D and Market June 21 - 22, 2017 Philadelphia, USA; USA 8th Molecular Immunology & Immunogenetics Congress March 20-21, 2017 Rome, Italy; 2nd International Congress on Contemporary Issues in Women Cancers and Gynaecologic Oncology Aug 28-29, 2017 London, UK; 9th International Conference on Haematology November 02-03, 2017 Las Vegas, USA; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference 27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Haematopoiesis January 31—February 4, 2017 Fairmont Banff Springs, Banff, Alberta, Canada; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference; 3rd EACR Conference on Cancer Genomics Cambridge, UK: 25 - 28 June 2017
Track 13: Immuno-Oncology studies:
Immuno-oncology therapies activate our immune system, making it able to recognise cancer cells and destroy them. Breast cancer is one of the major cancer types for which new immune-based cancer treatments are currently in development. Lung cancer surgery carries risks, including bleeding and infection. Clinical trials are studies of experimental lung cancer treatments. The immune system is the body’s natural defence system. It is a collection of organs, cells and special molecules that helps protect you from infections, cancer and other diseases. Adult central nervous system tumor is a disease in which abnormal cells form in the tissues of the brain and/or spinal cord. A tumor that starts in another part of the body and spreads to the brain is called a metastatic brain tumor. There are different types of brain and spinal cord tumors such as Astrocytic Tumors, Oligodendroglia Tumors, Mixed Gliomas, Ependymal Tumors, Medulloblastomas, Pineal Parenchymal Tumors, Meningeal Tumors, Germ Cell Tumors and Craniopharyngiom. Advances in Immuno-oncology have given oncologists and their patients reason to be encouraged—the launch of immune checkpoint inhibitors and development of other immunotherapy assets for the treatment of several difficult-to-treat diseases, including metastatic melanoma and non-small cell lung cancer, represents great progress.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: 9th world congress & expo on Immunology Conference, Oct 02-04, 2017, Toronto, Canada: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt.: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: ; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy: Stem Cells and Cancer meeting Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.
Track 14: Novel Approaches in Cancer & Tumor:
The epidermal growth factor receptor (EGFR) autocrine pathway contributes to a number of processes important to cancer development and progression, including cell proliferation, apoptosis, and angiogenesis. Immunotherapy encompasses several different treatment approaches, each of which has a distinct mechanism of action, and all of which are designed to boost or restore immune function in some manner. This includes: Monoclonal antibodies, Immune checkpoint inhibitors, Therapeutic Cancer vaccines, cytokines, and other non-specific immunotherapies. And mainly includes Metabolomics in Novel Biomarker Discovery.
Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC
Related Conferences: Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; 4th Asia Pacific Gastroenterology Cancer Summit, April 28-30, 2017 Singapore; 9th International Conference on Clinical and Experimental Haematology october 16-17, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 9th world congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada;25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; European Lung Cancer Conference, May 5-8, 2017, Switzerland; 2nd Paediatric Oncology Conference, June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom;
About Conference:
Conference Series delighted to invite you all to attend 10th International Conference on Cancer & Tumor Immunology to be held during October 26-27, 2017 Osaka, Japan with the Theme of “Explore the Possibilities in the Field of Cancer and Tumor” which covers a wide range of critically important sessions from basic research to innovations in the area of Immunology.
The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Cancer Tumor immunology 2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Cancer Tumor Immunology 2017 organizing committee look forward to meet you at Osaka, Japan.
For more details please visit: www.cancerimmunologymeeting.conferenceseries.com
Scope and Importance:
The global market for biological therapies for cancer was worth $37.9 billion in 2009, down from $38 billion in 2008. This number is expected to increase at a compound annual growth rate (CAGR) of 7.2% to reach $53.7 billion in 2014. And for cancer immunotherapies is expected to grow to nearly $67.9 billion by 2018, with a five-year compound annual growth rate (CAGR) of 14.7%. With rising instances of cancer and improving access to healthcare, America is far and away the largest segment in the overall market for cancer immunotherapies and is expected to grow to nearly $30.1 billion by 2018 at present’s analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018. The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2016 at a CAGR of 18.2%. The global market is broadly classified into product, cell type, technique, application, end-users, and regions. On the basis of technique, the market is segmented into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), microscopy, mass spectrometry, and others techniques.
Why in Japan?
Osaka is a designated city in the Kansai region of Japan. It is the capital city of Osaka Prefecture and the largest component of the Keihanshin Metropolitan Area, the second largest metropolitan area in Japan and among the largest in the world with over 19 million inhabitants. Situated at the mouth of the Yodo River on Osaka Bay, Osaka is the second largest city in Japan by daytime population after Tokyo’s 23 wards and the third largest city by night time population after Tokyo’s 23 wards and Yokohama, serving as a major economic hub for the country. Historically a merchant city, Osaka has also been known as the “nation’s kitchen” and served as a center for the rice trade during the Edo period. The city’s west side is open to Osaka Bay, and is otherwise completely surrounded by more than ten satellite cities, all of them in Osaka Prefecture, with one exception: the city of Amagasaki, belonging to HyÅgo Prefecture, in the northwest. The city occupies a larger area than any other city or village within Osaka Prefecture. When the city was established in 1889, it occupied roughly the area known today as the Chuo and Nishi wards, only 15.27 square kilometres that would eventually grow into today’s 222.30 square kilometres (54,932 acres) via incremental expansions, the largest of which being a single 126.01 square kilometres (31,138 acres) expansion in 1925
Major Associations for Cancer immunology
American Association for Cancer Research, Philadelphia
The American Association of Immunologists- Rockville, USA
International society of stem cell research- Indiana, USA
Association for Cancer Immunotherapy, Germany
Japanese Foundation for Cancer Research, Japan
Major Societies associated with Cancer immunology
Society for Immunotherapy of Cancer- Milwaukee, USA
Clinical Immunology Society -Warsaw, Indiana, USA
The Allergy and Immunology Society of Thailand -Bangkok, Thailand
French Society of Immunology-Paris, France
British Society for Immunology- London, UK
Indian Immunology Society, India
South African Stem Cell Transplantation Society (SA SCTS)-Addis Ababa, Ethiopia
Conference Highlights
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
| Conference Date | July 03-04, 2017 | ||
| Sponsors & Exhibitors |
|
||
| Speaker Opportunity Closed | |||
| Poster Opportunity Closed | Click Here to View | ||
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
Abstracts will be provided with Digital Object Identifier by